Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infectious Agents and Cancer
Published in: Infectious Agents and Cancer 1/2013

Open Access 01-12-2013 | Meeting report

Mentoring future Kenyan oncology researchers

Authors: Ann Moormann, Jodi Skiles, Emmanuel Koros, Fredrick Chite Asirwa, Naftali Busakhala, Patrick Loehrer

Published in: Infectious Agents and Cancer | Issue 1/2013

Login to get access

Abstract

This is a summary of the 1st Academic Model Providing Access to Healthcare (AMPATH) Oncology Institute research grant writing workshop organized in collaboration with the Kenya Medical Research Institute (KEMRI) and held in Kisumu, Kenya from January 16th to 18th, 2013. The goal of this meeting was to mentor future Kenyan scientists and prioritize research topics that would lead to improved cancer care and survival for the citizens of Kenya.
Appendix
Available only for authorised users
Literature
1.
Reed FA, Tishkoff SA: African human diversity, origins and migrations. Curr Opin Genet Dev. 2006, 16: 597-605. 10.1016/j.gde.2006.10.008.PubMedCrossRef
Metadata
Title
Mentoring future Kenyan oncology researchers
Authors
Ann Moormann
Jodi Skiles
Emmanuel Koros
Fredrick Chite Asirwa
Naftali Busakhala
Patrick Loehrer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2013
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/1750-9378-8-40

Other articles of this Issue 1/2013

Infectious Agents and Cancer 1/2013 Go to the issue

Research Article

Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study

Research article

HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study

Research article

Epstein Barr virus DNA analysis in blood predicts disease progression in a rare case of plasmablastic lymphoma with effusion

Research Article

Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011

Editorial

Learning lessons from cancer centers in low- and middle-income countries

Research article

Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits